Printer Friendly

MediciNova gives board seat to Tatsuo Izumi.

M2 PHARMA-September 26, 2011-MediciNova gives board seat to Tatsuo Izumi(C)2011 M2 COMMUNICATIONS

26 September 2011 - MediciNova Inc (NASDAQ:MNOV), a development-stage biopharmaceutical company, said on Monday that it had appointed Tatsuo Izumi to its board of directors.

The appointment was announced by Yuichi Iwaki, president and chief executive officer of MediciNova Inc, who praised Izumi's 50-year experience in accounting and financing and said he will be a great asset to the company and its shareholders.

Izumi has a bachelor's degree in economics from the Otaru University of Commerce. He is a Certified Public Tax Accountant and Certified Judicial Scrivener in Japan.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Sep 26, 2011
Words:114
Previous Article:Genentech's T-DM1 shows positive results in Phase II study in patients with mBC.
Next Article:Bayer unveils positive results of MAESTRAL study of Avelox.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters